Brilacidin

DRUG4 trials

Sponsors

Cellceutix Corporation, Innovation Pharmaceuticals, Inc.

Conditions

Bacterial InfectionCOVID-19Head and Neck NeoplasmsHealthy VolunteersMucositisSkin Infection

Phase 1

A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers

CompletedNCT04240223

Innovation Pharmaceuticals, Inc.Healthy Volunteers

Start: 2020-01-06End: 2020-02-12Updated: 2020-02-24

Phase 2

Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

CompletedNCT02052388

Cellceutix CorporationBacterial Infection, Skin Infection

Start: 2014-02-28End: 2014-10-31Updated: 2018-09-26

Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer

CompletedNCT02324335

Innovation Pharmaceuticals, Inc.Head and Neck Neoplasms, Mucositis

Start: 2014-08-14End: 2017-11-22Updated: 2019-01-16

A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19

CompletedNCT04784897

Innovation Pharmaceuticals, Inc.COVID-19

Start: 2021-02-22End: 2021-07-30Updated: 2022-09-16